Repeated alcohol intake leads to mesostriatal neuroadaptations, resulting in drinking escalation and addiction phenotypes. Fibroblast growth factor 2 (FGF2) has been shown to interact with the mesostriatal dopaminergic system, and has been implicated in the actions of psychostimulants in the brain, and in several psychiatric disorders. Here, we report on a positive regulatory feedback loop of alcohol and FGF2 in rodent models. Specifically, we found that acute alcohol exposure (2.5 g/kg, i.p.) increased the mRNA expression of Fgf2 in the dorsal hippocampus, nucleus accumbens, and dorsal striatum. Longer alcohol exposure (7 d ϫ 2.5 g/kg, i.p.) restricted these increases to the dorsal striatum, and the latter effect was blocked by the dopamine D2-like receptor antagonist haloperidol. Voluntary prolonged and excessive alcohol consumption in a 2-bottle choice procedure increased Fgf2 expression selectively in dorsomedial striatum (DMS) of both mice and rats. Importantly, we found that systemic administration of recombinant FGF2 (rFGF2) in mice, or rFGF2 infusion into the dorsal striatum or DMS of rats, increased alcohol consumption and preference, with no similar effects on saccharin or sucrose consumption. Finally, we found that inhibition of the endogenous FGF2 function in the DMS, by an anti-FGF2 neutralizing antibody, suppressed alcohol consumption and preference. Together, our results suggest that alcohol consumption increases the expression of Fgf2 in the DMS, and that striatal FGF2 promotes alcohol consumption, suggesting that FGF2 in the DMS is a positive regulator of alcohol drinking.
Introduction
Alcohol use disorder (AUD) is a chronic and relapsing psychiatric disorder affecting ϳ6%-10% of the population (American Psychiatric Association, 2013; World Health Organization, 2014) , characterized by excessive, out of control alcohol consumption and emergence of withdrawal syndrome during alcohol abstinence (American Psychiatric Association, 2013) . Alcohol consumption induces neuroadaptations in the brain reward system (i.e., the mesocorticolimbic dopaminergic system), which projects from the ventral tegmental area (VTA) to the nucleus accumbens (NAc), hippocampus, amygdala, and prefrontal cortex (PFC) (Koob and Volkow, 2009; Spanagel, 2009 ). These neuroadaptations are thought to account for the altered reward function in AUD (Berridge and Robinson, 1998; Nestler, 2001; Russo et al., 2010; .
It is increasingly accepted that the nigrostriatal system, which projects from the substantia nigra to the dorsal striatum, plays a pivotal role in goal-directed behaviors, as well as in the habitual and compulsive nature of alcohol addiction (Wise, 2009; Everitt and Robbins, 2013) . Thus, research using rodent models has shown that excessive alcohol intake leads to alterations in gene expression and signaling pathways in the dorsal striatum (e.g., McGough et al., 2004; Jeanblanc et al., 2006; Wang et al., 2007) , and these alterations play a crucial role in subsequent alcoholdrinking behaviors (Wang et al., 2007 (Wang et al., , 2011 Logrip et al., 2014; Ron and Barak, 2016) .
Fibroblast growth factor 2 (FGF2), a member of the FGF family consisting of 22 members, is implicated in brain development (Walicke et al., 1986; Ford-Perriss et al., 2001; Reuss and von Bohlen und Halbach, 2003) , adult neurogenesis (Wagner et al., 1999) , and regenerative plasticity (Gó mez-Pinilla et al., 1995) . In particular, FGF2 is involved in the development and maintenance of midbrain dopaminergic neurons (Reuss and Unsicker, 2000; Reuss and von Bohlen und Halbach, 2003; Grothe and Timmer, 2007) .
The psychostimulants cocaine and amphetamine have been shown to increase FGF2 levels in several brain regions. Specifically, cocaine treatment upregulates Fgf2 mRNA levels in the striatum, PFC, and hippocampus (Fumagalli et al., 2006) , and repeated administration of amphetamine leads to long-lasting increases in FGF2 immunoreactivity in the VTA and substantia nigra (Flores and Stewart, 2000a) . FGF2 expression positively correlates with the magnitude of psychostimulants-induced locomotor sensitization (Flores and Stewart, 2000a ), considered to model addiction-related neuroadaptations (Robinson and Berridge, 2001 ). Furthermore, repeated administration of amphetamine results in an FGF2-mediated increase in dendritic growth of VTA dopaminergic neurons (Mueller et al., 2006) . Together, these findings indicate that FGF2 is involved in the development of psychostimulant sensitization and may be involved in molecular mechanisms relevant to addiction.
Here, we tested whether alcohol exposure alters the expression of Fgf2 in mesolimbic and nigrostriatal brain regions, and if so, whether FGF2 regulates alcohol intake.
Materials and Methods

Animals
Male and female C57BL/6J mice and Wistar rats (20 -25 g and 175-200 g at the beginning of experiments, respectively) were bred in Tel Aviv University animal facility and housed under a 12 h light/dark cycle (mice lights on at 4:00 A.M., rats lights on at 7:00 A.M.) with food and water available ad libitum. Animals were individually housed, except for alcohol-injection experiments, in which mice were housed 4 per cage. All experimental protocols conformed to the guidelines of the Institutional Animal Care and Use Committee of Tel Aviv University and of the National Institutes of Health. All efforts were made to minimize the number of animals and their suffering.
Reagents and drug preparation
Fast SYBR Green Master Mix (#4385617), TRIzol reagent (#13150101), and RevertAid kit (#0442) were supplied by Thermo-Fisher Scientific. DNA oligonucleotides (qRT-PCR primers), haloperidol (#H1512), and isopropanol (#563935) were obtained from Sigma-Aldrich. Isoflurane was obtained from Piramal Critical Care. Neutralizing antibody against FGF2 (05-117) and control IgG (12-371) were purchased from Millipore. Ethyl alcohol (absolute), purchased from Gadot, was diluted to 20% alcohol (vol/vol) in saline (for alcohol injection) or in tap water (for voluntary consumption). Haloperidol was dissolved in saline containing 0.1% acetic acid; pH was corrected to 6.0 with NaOH. Recombinant FGF2 (rFGF2) was purchased from Prospec (#CYT-386) and dissolved in PBS containing 0.1% BSA.
Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)
Following brain dissection, tissue samples were immediately snap-frozen in liquid nitrogen and stored at Ϫ80°C until use. Frozen tissues were mechanically homogenized in TRIzol reagent and total RNA was isolated from each sample according to the manufacturer's recommended protocol. mRNA was reverse transcribed to cDNA using the Reverse Transcription System and RevertAid kit. Plates of 96 wells were prepared for the SYBR Green cDNA analysis using Fast SYBR Master Mix. Samples were analyzed in triplicate with a Real-Time PCR System (StepOnePlus; Applied Biosystems), and quantified against an internal control gene, Gapdh. We used the following reaction primers sequences: mice; Fgf2 forward, 5Ј-CGT CAA ACT ACA ACT CCA AGCAG-3Ј; reverse, 5Ј-TCC AGT CGT TCA AAG AAG AAA CAC-3Ј; Gapdh forward, 5Ј-CCA GAA CAT CAT CCC TGC-3Ј; reverse, 5Ј-GGA AGG CCA TGC CAG TGAGC-3Ј; rats; Fgf2 forward, 5Ј-AGT TGT GTC CAT CAA GGG ATGT-3Ј; reverse, 5Ј-AGC CAG CAG CCG TCCAT-3Ј; Gapdh forward, 5Ј-GCA AGA GAG AGG CCC TCAG-3Ј; reverse, 5Ј-TGT GAG GGA GAT GCT CAGTG-3Ј. Thermal cycling was initiated with incubation at 95°C for 20 s (for SYBR Green activation), followed by 40 cycles of PCR with the following conditions: heating at 95°C for 3 s and then 30 s at 60°C. Relative quantification was calculated using the ⌬⌬C t method.
Intermittent access to 20% alcohol in 2-bottle choice (IA2BC)
After 1 week of habituation for individual housing, mice or rats were trained to consume alcohol in the IA2BC procedure as previously described (Neasta et al., 2010; Hwa et al., 2013; Warnault et al., 2013; . Briefly, animals received three 24-h sessions of free access to 2-bottle choice per week (tap water and 20% alcohol v/v) on Sundays, Tuesdays, and Thursdays, with 24 or 48 h of alcohol-deprivation periods between the alcohol-drinking sessions. During the withdrawal periods, animals received only water. The position (left or right) of each solution was alternated between each session to control for side preference. Water and alcohol bottles were weighed before and after each alcohol-drinking session, and consumption levels were normalized to body weight. Training lasted 5 weeks for mice, and 7 weeks for rats, before the brain tissue collection, surgical or pharmacological manipulations.
Intermittent access to saccharin or sucrose in 2-bottle choice
This procedure was conducted as previously described (Warnault et al., 2013) . Training was similar to the IA2BC procedure described above, except that mice had access to saccharin (0.005% and 0.03% w/v) or sucrose (0.2% and 1% w/v) solutions instead of alcohol, and training lasted 3 weeks before rFGF2 treatment. Solutions intake was normalized to body weight.
Surgery and intracerebral microinfusion
Surgery and microinfusion were conducted as previously described (Barak et al., 2011a (Barak et al., , b, 2013 Ahmadiantehrani et al., 2014) . Rats were anesthetized continuously with isoflurane and mounted on a stereotaxic apparatus (Kopf Instruments). Guide cannulae (26 gauge; Plastics One) were aimed dorsal to the target areas: dorsal striatum (in millimeters relative to bregma: 1.2 anteroposterior, Ϯ2.5 mediolateral, Ϫ3.9 dorsoventral) and dorsomedial striatum (DMS; 1.2 anteroposterior, Ϯ1.5 mediolateral, Ϫ4.4 dorsoventral), according to the Rat Brain Atlas (Paxinos and Watson, 2007) . The DMS coordinates were chosen based on . After recovery, habituation to the microinfusion procedure, and reestablishment of baseline consumption levels (3 weeks), rFGF2 (200 ng/0.75 l/hemisphere), or anti-FGF2 neutralizing antibody (750 ng/0.75 l/hemisphere), or corresponding vehicle, was infused in gently restrained rats over 1.5 min via injection cannula (33 gauge, Plastics One), extending 0.5 mm beyond the guide cannula tip into the target region. Injection cannulae were left in place for 2 additional minutes. rFGF2 concentration was based on previous studies (Turner et al., 2008; Graham and Richardson, 2011) . The concentration of anti-FGF2 neutralizing antibody was chosen based on Hafenbreidel et al. (2015) .
Histology
Locations of cannulae were verified in 30 m coronal sections of PFAfixed tissue stained with cresyl violet. Only data from subjects with cannulae located in the region of interest were included in the analysis.
Experimental design and statistical analysis
Sex approximately equally distributed across experiments and was initially analyzed as a factor; however, all analyses did not yield a main effect of sex or any interaction with other factors ( p values Ͼ0.05). Therefore, the data were collapsed across this factor. The rationale for the experiments is described in Results.
Fgf2 expression experiments.
In these experiments, we tested the effects of alcohol exposure on Fgf2 expression in several brain regions. The mRNA expression of Fgf2 was normalized to Gapdh expression (Zipori et al., 2017) , which we found to be unaffected by alcohol in the protocols we used (Fig. 1-1 , available at https://doi.org/10.1523/JNEUROSCI. 0890-17.2017.f1-1). Expression in each brain region was further normalized to its own control group (saline-or water-treated group).
First, we tested the effects of acute or subchronic alcohol administration on Fgf2 expression. Data were analyzed by one-way ANOVA, with a between-subjects factor of Time after the last alcohol injection. ANOVA was followed by Student-Newman-Keuls post hoc analyses throughout the study.
Next, we tested whether the effect of subchronic alcohol treatment on Fgf2 expression in the dorsal striatum was mediated by dopamine D2-like receptors. In this experiment, expression data were analyzed by two-way ANOVA, with between-subjects factors of Pretreatment (haloperidol, vehicle) and Treatment (alcohol, saline).
In the next set of experiments, we tested the effects of voluntary alcohol consumption on Fgf2 expression. Mice were trained to consume alcohol in the IA2BC drinking protocol, and Fgf2 levels were determined at the end of a 24-h alcohol drinking session or of a 24-h alcohol-withdrawal session. Data were analyzed by one-way ANOVA, with a betweensubjects factor of Time point. Finally, we tested the effects of voluntary alcohol intake (IA2BC drinking protocol, in mice and rats) on Fgf2 expression in the dorsal striatum subregions: DMS and dorsolateral striatum (DLS). mRNA expression levels were measured at the end of a 24 h alcohol-withdrawal period and compared with a water-drinking control group by independent t tests with a between-subjects factor of Time point.
Alcohol, saccharin, or sucrose consumption experiments. In this set of experiments, we tested the effects of rFGF2, administered systemically in mice, or infused into the dorsal striatum in rats, on the consumption and preference of the reward, as well as on water and total fluid intake.
First, we tested the effects of systemic rFGF2 or vehicle administration on alcohol (20%), saccharin (0.005%, 0.03%), or sucrose (0.2%, 1%) consumption. In the alcohol consumption experiment, data were analyzed by independent t tests (a between-subjects factor of Treatment). In the saccharin and sucrose experiments, data were analyzed by a 2 ϫ 2 mixed-model ANOVA, with a between-subjects factor of Treatment (rFGF2, vehicle) and a within-subjects factor of solution Concentration. . A, Alcohol (2.5 g/kg, 20%, i.p.) or saline was administered once, 2 h (Alcohol 2 h), 6 h (Alcohol 6 h), or 24 h (Alcohol 24 h) before brain tissue collection. n ϭ 5-8 per group. B, Alcohol (2.5 g/kg, 20%, i.p.) or saline was administered once a day for 7 d. Brain tissues were collected 2 h (Alcohol 2 h) or 24 h (Alcohol 24 h) after the last alcohol injection. n ϭ 5-10 per group. A, B, Fgf2 mRNA levels were determined by qRT-PCR and normalized to Gapdh, which was not affected by alcohol on its own ( Fig. 1-1 , available at https://doi.org/10.1523/JNEUROSCI.0890-17.2017.f1-1). Bar graphs indicate mean ϩ SEM. Each brain region was normalized to its saline control. C, Schematic representation of the sampling regions. *p Ͻ 0.05 compared with saline control. **p Ͻ 0.01 compared with saline control.
The effects of intracerebral rFGF2 on alcohol intake and preference, as well as on water and total fluid intake, were tested in a counterbalanced within-subjects design. Data were analyzed by paired-sample t tests, with a within-subjects factor of Treatment.
Finally, we tested the effect of FGF2 inhibition on alcohol consumption. Anti-FGF2 neutralizing antibody and control IgG were infused into the rat DMS in a counterbalanced within-subjects design, and data were analyzed by paired-sample t tests (a within-subjects factor of Treatment).
Results
Acute and subchronic alcohol treatments increase Fgf2
mRNA expression First, we tested whether acute alcohol treatment changes the mRNA expression of Fgf2. We focused on mesolimbic/striatal brain regions that were previously implicated in alcohol-drinking behaviors (Ron and Barak, 2016) , namely, the NAc, dorsal striatum, and dorsal hippocampus. Mice received a single injection of alcohol (2.5 g/kg in a 20% alcohol v/v solution, i.p.) or saline, and we dissected these brain regions 2, 6, and 24 h later.
We found that alcohol increased Fgf2 mRNA levels in a timeand brain region-specific manner (Fig. 1A) . Specifically, we observed an increase in Fgf2 expression in the dorsal striatum 2 h after alcohol injection, but the expression levels of the growth factor returned to baseline levels 6 h after alcohol injection (oneway ANOVA, F (3,33) ϭ 6.46, p ϭ 0.002; post hoc, 2 h vs saline, p ϭ 0.027). In addition, alcohol increased Fgf2 expression in the NAc 2 and 24 h (but not 6 h) after alcohol injection (one-way ANOVA, F (3,34) ϭ 7.15, p ϭ 0.001; post hoc, 2 h vs saline, p ϭ 0.003, or 24 h vs saline, p ϭ 0.021). Finally, alcohol increased Fgf2 expression in the dorsal hippocampus 24 h after alcohol injection (one-way ANOVA, F (3,26) ϭ 4.71, p ϭ 0.01; post hoc, 24 h vs saline, p ϭ 0.011).
Next, we determined the effects of a longer alcohol treatment on the expression of Fgf2. Mice were injected with alcohol (2.5 g/kg in a 20% alcohol v/v solution, i.p.) or saline once a day for 7 d. Mice were killed 2 or 24 h after the last alcohol injection, as we did not observe any changes in Fgf2 expression at the 6 h time point following the acute treatment. As shown in Figure 1B , we found that this subchronic alcohol treatment also increased Fgf2 mRNA levels in the dorsal striatum 2 h, but not 24 h after the last alcohol injection (one-way ANOVA, F (2,14) ϭ 9.66, p ϭ 0.002; post hoc, 2 h vs saline, p ϭ 0.003). No significant changes in the growth factor's expression were detected in the NAc or dorsal hippocampus ( p values Ͼ0.15).
Together, these data indicate that short alcohol exposure increases Fgf2 expression in the NAc, dorsal striatum, and dorsal hippocampus, brain regions that were previously implicated in alcohol-drinking behaviors (Koob and Volkow, 2016; Ron and Barak, 2016) . However, more extended alcohol exposure restricts the increases in Fgf2 expression to the dorsal striatum.
Dopamine D2-like receptors mediate the alcohol-induced increase in striatal Fgf2
Alcohol has been shown to increase mesolimbic and nigrostriatal dopamine levels (Di Chiara and Imperato, 1988; Gonzales et al., 2004) , and we show here that striatal Fgf2 expression is increased by alcohol. Furthermore, treatment with a dopamine D2 receptor (D2R) agonist was shown to increase Fgf2 mRNA expression, whereas agonists of the D1 or D3 receptors had no such effect . Thus, we next tested whether the effects of alcohol on Fgf2 expression in the dorsal striatum are mediated by dopamine D2-like activation.
To test this possibility, we used the repeated alcohol injection protocol as above, which yielded an ϳ50% increase in Fgf2 mRNA expression in the dorsal striatum 2 h after treatment (Fig. 1B) . Therefore, we pretreated mice once a day for 7 d with the dopamine D2-like receptor antagonist haloperidol (1 mg/kg, i.p.) (Roceri et al., 2001) or vehicle. Each day, 1 h after haloperidol injection, mice received an alcohol (2.5 g/kg in a 20% alcohol v/v solution, i.p.) or saline injection. We then tested Fgf2 mRNA levels, 2 h after the last alcohol injection.
As shown in Figure 2 , we found that alcohol treatment increased the expression of Fgf2 in the dorsal striatum, replicating our results above. However, haloperidol blocked the effect of alcohol and normalized Fgf2 expression. These results indicate that dopamine D2-like receptors mediate the alcohol-induced increases in Fgf2 expression in the dorsal striatum (two-way ANOVA; haloperidol Pretreatment ϫ alcohol Treatment interaction, F (1, 20) ϭ 4.87, p ϭ 0.039) but no significant main effects of Pretreatment or Treatment ( p values Ͼ0.47): post hoc, vehiclesaline vs vehicle-alcohol, p ϭ 0.027, and vehicle-alcohol vs haloperidol-alcohol, p ϭ 0.015).
Voluntary alcohol consumption increases the expression of Fgf2 in the dorsal striatum Next, we determined the effects of voluntary alcohol drinking on the expression of Fgf2. Mice were trained to consume alcohol in the IA2BC drinking procedure (Neasta et al., 2010; Warnault et al., 2013) for 5 weeks. In this drinking protocol, mice consume high quantities of alcohol, typically yielding an average alcohol consumption of 10 -15 g/kg/24 h, which generates blood alcohol concentration of Ͼ100 mg/dl after binge-like drinking at the first hours of drinking (Hwa et al., 2011; Griffin, 2014; Ron and Barak, 2016) . The NAc, dorsal striatum, and dorsal hippocampus of mice were collected at the end of a 24-h alcohol drinking session (mean alcohol consumption: ϳ10 Ϯ 0.75 g/kg/24 h, alcohol pref- Figure 2 . Alcohol-induced increase in Fgf2 expression in the dorsal striatum is mediated by dopamine D2-like receptors. Mice were pretreated with the dopamine D2-like receptor antagonist haloperidol (1 mg/kg, i.p.) or vehicle, and 1 h later were treated with alcohol (2.5 g/kg, 20%, i.p.) or saline, once a day for 7 d. The dorsal striatum was collected 2 h after the last alcohol injection. Fgf2 mRNA levels were determined by qRT-PCR and normalized to Gapdh, which was not affected by alcohol on its own (Fig. 1-1 , available at https://doi.org/10.1523/JNEUROSCI. 0890-17.2017.f1-1). Bar graphs indicate mean ϩ SEM, normalized to the saline ϩ vehicle control group. n ϭ 5-7 per group. *p Ͻ 0.05. erence ϳ50 Ϯ 3.5%) or after a 24-h alcohol withdrawal period. Control mice consumed only water.
We found that alcohol consumption led to a ϳ2.5-fold increase in Fgf2 expression in the dorsal striatum, compared with water-drinking controls, and this increase was still detected after a 24-h alcohol withdrawal period ( Fig. 3 ; one-way ANOVA, F (2,22) ϭ 24.52, p Ͻ 0.0001; post hoc, alcohol/withdrawal vs water, p values Ͻ 0.0001). No changes were found in the expression of Fgf2 in the dorsal hippocampus or the NAc ( p values Ͼ0.43). These results suggest that long-term consumption of excessive levels of alcohol leads to a stable increase in Fgf2 expression, selectively in the dorsal striatum.
Systemic rFGF2 administration increases voluntary alcohol but not saccharin or sucrose consumption
Our results indicate that alcohol leads to an increased expression of Fgf2, and that this increase is still seen after 24 h of alcohol deprivation. Therefore, we next tested whether increasing the levels of FGF2 would affect alcohol consumption and preference.
Mice were trained to consume alcohol in the IA2BC procedure for 5 weeks, as detailed above. rFGF2 (40 or 80 g/kg in two separate experiments, s.c.) or vehicle was injected 1 h before the beginning of the drinking session. We found that mice treated with 80 g/kg rFGF2, but not 40 g/kg rFGF2, consumed more alcohol compared with vehicle-treated mice ( Fig. 4 ; 40 g/kg: t (16) ϭ 0.96, p ϭ 0.35; 80 g/kg: t (12) ϭ 2.63, p ϭ 0.022). Importantly, this effect was specific to alcohol, as water consumption and total fluid intake were not affected by rFGF2 (p values Ͼ0.177). In addition, we found a trend toward an increase in alcohol preference at 80 g/kg (t (12) ϭ 1.79, p ϭ 0.09).
Next, we tested whether the effects of rFGF2 are specific to alcohol or are due to a more generalized effect on reward consumption. Thus, we next tested whether rFGF2 also affects the consumption of sweetened solutions (saccharin, which has no caloric value, or sucrose, which, like alcohol, has caloric value). Mice were trained to consume saccharin (0.005%, 0.03%) or sucrose (0.2%, 1%) in an intermittent access 2-bottle choice (water and saccharin/sucrose) procedure for 3 weeks. rFGF2 (80 g/kg, s.c.) or vehicle was administered 1 h before the beginning of a drinking session. We found that rFGF2 had no effects on saccharin or sucrose intake or preference at any of the solution concentrations ( Fig. 4G-J ; p values Ͼ0.60). Importantly, our data indicated an increase in saccharin and sucrose consumption as a function of their concentration (mixed-model ANOVA, saccharin: F (1,19) ϭ 64.75, p Ͻ 0.0001; sucrose: F (1,22 ϭ 26.22, p Ͻ 0.0001), ruling out the possibility that rFGF2 failed to increase the consumption of the sweet solutions due to a ceiling effect.
Infusion of rFGF2 into the dorsal striatum increases voluntary alcohol consumption and preference
We found that a history of excessive alcohol consumption led to upregulation of Fgf2 expression selectively in the dorsal striatum and that systemic administration of the growth factor increased alcohol intake. To test whether the latter effect is mediated by the dorsal striatum, we next infused rFGF2 into the dorsal striatum of rats with a long-history of excessive alcohol drinking.
Rats were trained to consume alcohol in the IA2BC drinking procedure for 7 weeks . In this drinking protocol, Wistar rats typically show an average alcohol consumption of 3.5-5.5 g/kg/24 h, which generates blood alcohol concentration of Ͼ60 mg/dl after binge-like drinking during the first hours of drinking (Cippitelli et al., 2012; Carnicella et al., 2014). rFGF2 (200 ng/0.75 l per hemisphere) and vehicle were infused into the dorsal striatum in a counterbalanced within- ) . A, Experimental timeline scheme. Mice consumed alcohol in the intermittent access to 20% alcohol in 2-bottle choice paradigm for 5 weeks. Control mice consumed water only. Tissues were collected immediately at the end of the last 24-h drinking session (Alcohol group) or 24 h after the termination of the last drinking session (Withdrawal group). B, Fgf2 mRNA levels were determined by qRT-PCR, and normalized to Gapdh, which was not affected by alcohol on its own ( Fig. 1-1 , available at https://doi.org/10.1523/JNEUROSCI.0890-17.2017.f1-1). Bar graphs indicate mean ϩ SEM. Each brain region was normalized to its water control. n ϭ 8 or 9 per group. **p Ͻ 0.01 compared with water control. subjects design, 10 min before the beginning of a 24-h alcohol drinking session.
As depicted in Figure 5 , we found that rFGF2 infusion increased alcohol consumption (t (13) ϭ 3.67, p ϭ 0.003) and preference (t (13) ϭ 2.60, p ϭ 0.022). rFGF2 did not alter water consumption ( p ϭ 0.55), further indicating that the growth factor increased alcohol consumption without affecting other consummatory behaviors. Because alcohol intake was increased by rFGF2 without an effect on water intake, the total fluid intake was increased (t (13) ϭ 3.88, p ϭ 0.002). Interestingly, rFGF2 did not affect alcohol consumption or preference in the first 30 min or 4 h of drinking ( p values Ͼ0.12). These results indicate that FGF2 in the dorsal striatum is an enhancer of alcohol consumption and that its action involves slow-onset mechanisms. D, Preference to alcohol. E, Water intake (ml/kg). F, Total fluid intake (alcohol ϩ water; ml/kg). G, Saccharin (0.005% or 0.03%) solution intake (ml/kg). H, Preference for saccharin solution. I, Sucrose (0.2% or 1%) solution intake (ml/kg). J, Preference for sucrose solution. Bar graphs indicate mean ϩ SEM. n ϭ 7-11 per group. *p Ͻ 0.05; # p ϭ 0.09.
The effect of excessive alcohol consumption on Fgf2 expression is localized to the DMS
( White and McDonald, 2002; Featherstone and McDonald, 2004; Yin et al., 2004) and in compulsive alcohol/drug consumption (Everitt and Robbins, 2005; Corbit et al., 2012 ). Because we found that excessive voluntary alcohol intake led to upregulation of Fgf2 expression in the dorsal striatum (Fig. 3) , we next tested whether this effect was localized to the DMS and/or DLS. We trained both mice and rats in the IA2BC procedure, as detailed above (average consumption in the last 24-h drinking session: mice, ϳ15 Ϯ 0.79 g/kg, preference levels: ϳ55 Ϯ 2.5%; rats, ϳ4.3 Ϯ 0.5 g/kg, preference levels: ϳ55 Ϯ 7%). Control rodents consumed only water. Because we observed increased levels of Fgf2 expression both after a 24-h alcohol-drinking session and after the following 24 h of withdrawal (Fig. 3B) , here brains were collected only at the latter time point. This time point is of particular interest, as it corresponds to the beginning of the next alcohol-drinking session, as well as to the timing we administered rFGF2.
As depicted in Figure 6 , we found that, following withdrawal from voluntary alcohol consumption, Fgf2 expression was upregulated in the DMS, but not in the DLS of both mice and rats. These results suggest that the striatal increases in Fgf2 expression, induced by excessive consumption of alcohol, are localized to the DMS (DMS: mice, t (9) ϭ 2.67, p ϭ 0.026; rats, t (10) ϭ 2.37, p ϭ 0.039; DLS: both species, p values Ͼ0.67).
Infusion of rFGF2 into the DMS increases voluntary alcohol consumption and preference
Because we found that withdrawal from excessive alcohol consumption increases Fgf2 expression selectively in the dorsomedial subregion of the striatum, we next tested whether the effects of rFGF2 on alcohol intake were also localized to this brain region. Rats were trained to consume alcohol in the IA2BC procedure for 7 weeks, as described above. rFGF2 (200 ng/0.75 l per hemisphere) and vehicle were infused into the DMS in a counterbalanced within-subjects design, 10 min before the beginning of a 24-h alcohol drinking session.
As shown in Figure 7 , we found that rFGF2 treatment increased alcohol consumption and preference, compared with vehicle (paired t test; consumption: t (7) ϭ 2.93, p ϭ 0.022; preference: t (7) ϭ 4.11, p ϭ 0.05). Moreover, although rFGF2 reduced water intake (t (7) ϭ 2.85, p ϭ 0.025), it did not affect Figure 5 . FGF2 infusion into the dorsal striatum leads to increased alcohol consumption and preference. Rats were trained to consume alcohol in the intermittent access to 20% alcohol in 2-bottle choice paradigm for 7 weeks before cannulation. Recombinant FGF2 (200 ng/0.75 l per hemisphere) or vehicle was infused into the dorsal striatum, 10 min before the beginning of an alcohol-drinking session. Alcohol and water intake was measured after 30 min, 4 h, and 24 h. A, Amount of alcohol (g/kg) consumed. B, Preference for alcohol, calculated as the ratio of the volume of alcohol solution intake/volume of total fluid intake. C, Water intake (ml/kg). D, Total fluid intake (alcohol ϩ water; ml/kg). E, Schematicrepresentationofthecannulatipplacementincoronalsections (bregma ϩ mm). Bar graphs indicate mean ϩ SEM adjusted for a within-subjects design (Cousineau, 2005) . n ϭ 14 per group. *p Ͻ 0.05; **p Ͻ 0.01. the total fluid intake ( p ϭ 0.118). These results suggest that increasing the levels of FGF2 in the DMS enhances alcohol consumption.
Inhibition of FGF2 activity in the DMS reduces alcohol consumption and preference
Our results suggest that FGF2 in the DMS is a positive regulator of alcohol intake. If so, inhibition of FGF2 activity in this brain region is expected to reduce alcohol consumption. Therefore, we next determined the effects of inhibition of FGF2 function in the DMS on alcohol intake. We used a neutralizing antibody against FGF2 (Mueller et al., 2006; Hafenbreidel et al., 2015) to inhibit the function of the growth factor. This neutralizing antibody selectively targets FGF2, with no cross-reactivity to FGF1 (Matsuzaki et al., 1989; Tao et al., 1997) .
Rats were trained to consume alcohol in the IA2BC procedure, as described above. Anti-FGF2 neutralizing antibody (750 ng/0.75 l per hemisphere) and control IgG were infused into the DMS in a counterbalanced within-subjects design, 1 h before the beginning of a 24 h alcohol drinking session.
As detailed in Figure 8 , we found that inhibition of FGF2 function in the DMS suppressed alcohol consumption and preference, compared with the control treatment (paired t test; consumption: t (14) ϭ 2.81, p ϭ 0.014; preference: t (14) ϭ 4.35, p ϭ 0.001). Although inhibition of FGF2 increased water intake (t (14) ϭ 2.90, 0.012), it did not affect the total fluid intake ( p ϭ 0.54). These results indicate that deceasing FGF2 activity in the DMS suppresses alcohol consumption, suggesting that the endogenous FGF2 positively regulates alcohol-drinking behavior.
Discussion
Our results demonstrate the involvement of FGF2 in alcoholdrinking behaviors, raising the possibility that this growth factor is involved in the escalation and maintenance of alcohol drinking. Our main findings are as follows: (1) a history of excessive alcohol drinking results in a sustained increase in Fgf2 mRNA levels in the DMS; (2) rFGF2 increases alcohol consumption and preference, and its action is localized to the DMS; and (3) inhibition of the endogenous FGF2 in the DMS suppresses alcohol intake. Based on these findings, we propose that excessive alcohol drinking leads to elevated FGF2 levels in the DMS, which in turn promote excessive alcohol consumption. Thus, these bidirectional effects provide a positive regulatory feedback loop of alcohol and FGF2, possibly contributing to the escalation in alcohol intake. . Voluntary alcohol consumption increases Fgf2 expression in the DMS of mice and rats. A, Experimental timeline scheme. Mice and rats consumed alcohol in the intermittent access to 20% alcohol in 2-bottle choice paradigm. Control animals consumed water only. Tissues were collected 24 h after the termination of the last drinking session (Withdrawal group). B, C, Fgf2 mRNA levels were determined by qRT-PCR in the DMS and DLS of mice (B) and rats (C), and normalized to Gapdh. Bar graphs indicate mean ϩ SEM. Each brain region was normalized to its water control. D, Schematic representation of the sampling regions. n ϭ 5 or 6 per group. *p Ͻ 0.05 compared with water control.
FGF2 is an alcohol-responsive gene
We show that acute alcohol exposure leads to increased expression of the Fgf2 transcript in the NAc, dorsal striatum, and dorsal hippocampus. Interestingly, as alcohol exposure extended, its effects on Fgf2 expression became more specific and spatially restricted. Specifically, short-term exposure to alcohol (7 daily injections) increased Fgf2 expression only in the dorsal striatum shortly after the last injection, but the expression levels returned to baseline after 24 h. Long-term voluntary consumption of excessive alcohol levels increased Fgf2 expression exclusively in the DMS. Thus, as the exposure to alcohol extends and becomes more robust, the effects on Fgf2 expression become more specific and stable.
We further show that the striatal increase in Fgf2 expression following repeated alcohol injections was blocked by haloperidol, suggesting that this effect is mediated via dopamine D2-like receptor activation. Given that alcohol injections increase dopamine levels in the dorsal striatum (Di Chiara and Imperato, 1988) , it is likely that alcohol increases striatal Fgf2 levels by increasing dopamine levels, which activate dopamine D2-like receptors. As haloperidol was reported to have low affinity to additional receptors (e.g., sigma1 receptor and ␣-1a andrenoreceptor) (Walker et al., 1988; Richelson and Souder, 2000) , we cannot rule out the involvement of these receptors in the effects of alcohol on Fgf2. Moreover, withdrawal from prolonged excessive alcohol drinking leads to an allostatic reduction in dopamine levels (Weiss et al., 1996; Barak et al., 2011a) . Therefore, it is possible that, after a long period of alcohol exposure, additional mechanisms are involved in the upregulation of Fgf2 expression (e.g., glutamatergic or GABAergic neurotransmission), which were previously implicated in modulation of FGF2 expression (Riva et al., 1994; Flores and Stewart, 2000a; Gó mez-Pinilla et al., 2000) .
Importantly, it has previously been reported that increases in the Fgf2 mRNA levels in the striatum, PFC, and hippocampus caused by nicotine (Roceri et al., 2001 ) and the D2R agonist quinpirole are accompanied by a similar increase in the FGF2 protein levels. Thus, it is likely that the transcriptional changes in Fgf2, which we observed, translate into changes in the protein levels.
FGF2 positively regulates alcohol consumption
Upon showing that Fgf2 expression is increased in the DMS after a history of excessive alcohol consumption, we show that FGF2 Figure 7 . FGF2 infusion into the DMS increases alcohol consumption and preference. Rats were trained to consume alcohol in the intermittent access to 20% alcohol in 2-bottle choice paradigm for 7 weeks before cannulation. Recombinant FGF2 (200 ng/0.75 l per hemisphere) or vehicle was infused into the DMS 10 min before the beginning of an alcohol-drinking session. Alcohol and water intake was measured at the end of the 24-h drinking session. A, Amount of alcohol (g/kg) consumed. B, Preference for alcohol, calculated as the ratio of the volume of alcohol solution intake/volume of total fluid intake. C, Water intake (ml/kg). D, Total fluid intake (alcohol ϩ water; ml/kg). E, Schematic representation of the cannula tip placement in coronal sections (bregma ϩ mm). Bar graphs indicate mean ϩ SEM adjusted for a within-subjects design (Cousineau, 2005) . n ϭ 8 per group. *p Ͻ 0.05; **p Ͻ 0.01.
regulates alcohol consumption. Specifically, systemic administration of rFGF2 to mice, as well as focal infusion of rFGF2 into the dorsal striatum, or more specifically into the DMS of rats, led to increased alcohol intake and preference. Importantly, the effect of rFGF2 was specific to alcohol, as it did not increase the consumption of water, saccharin, or sucrose. Interestingly, rFGF2 administration had no effects during the initial 4 h of the drinking session. This delayed-onset effect suggests that the actions of FGF2 may require transcriptional and/or translational mechanisms, which lead to increased alcohol intake in a delayed manner.
We further found that inhibition of the endogenous FGF2 in the rat DMS, by infusion of an anti-FGF2 neutralizing antibody, suppressed alcohol consumption and preference. These results indicate that the endogenous FGF2 function is required for consumption of high levels of alcohol. Together, our findings that bidirectional manipulations on FGF2 yield opposite effects on alcohol consumption provide strong evidence for the role of FGF2 in the DMS as a pivotal positive regulator of alcoholdrinking behaviors.
Relevantly, it was previously reported that inhibition of FGF2 in the VTA, by anti-FGF2 neutralizing antibody, blocked the development of amphetamine-induced psychomotor sensitization (Flores et al., 2000) . Moreover, FGF2 inhibition in the infralimbic cortex enhanced extinction of operant cocaine self-administration (Hafenbreidel et al., 2015) . Finally, rats selectively bred to show low novelty responses, which were shown to express reduced brain Fgf2 levels Clinton et al., 2012) , exhibited lower levels of operant cocaine self-administration (Cummings et al., 2011) and sensitization (Clinton et al., 2012) , compared with controls. Together with the current findings, these findings suggest that the endogenous FGF2 regulates drug-related behaviors, including drug-seeking and consumption.
Interestingly, our finding that FGF2 is a positive regulator of alcohol consumption sets it apart from other growth factors that negatively regulate alcohol intake (Ghitza et al., 2010; Ron and Barak, 2016) . Thus, downregulation of brain-derived neurotrophic factor (Bdnf ) expression in the DLS Logrip et al., 2015) , or of glial cell line-derived neurotrophic factor (Gdnf ) in the VTA or NAc ( . Inhibition of FGF2 activity in the DMS decreases alcohol consumption and preference. Rats were trained to consume alcohol in the intermittent access to 20% alcohol in 2-bottle choice paradigm for 7 weeks before cannulation. Neutralizing antibody against FGF2 (750 ng/0.75 l per hemisphere) or control IgG was infused into the DMS 1 h before the beginning of an alcoholdrinking session. Alcohol and water intake was measured at the end of the 24-h drinking session. A, Amount of alcohol (g/kg) consumed. B, Preference for alcohol, calculated as the ratio of the volume of alcohol solution intake/volume of total fluid intake. C, Water intake (ml/kg). D, Total fluid intake (alcohol ϩ water; ml/kg). E, Schematic representation of the cannula tip placement in coronal sections (bregma ϩ mm). Bar graphs indicate mean ϩ SEM adjusted for a within-subjects design (Cousineau, 2005) . n ϭ 15 per group. *p Ͻ 0.05; **p Ͻ 0.01. brain regions attenuates alcohol intake. These opposite effects of FGF2 and other growth factors may be due to their action at different brain regions and/or via different downstream processes.
Alcohol and FGF2, a positive feedback regulatory loop for drinking escalation?
We used here an alcohol-drinking protocol that consists of repeated cycles of 24 h alcohol consumption and withdrawal sessions. Critically, our findings indicate that Fgf2 expression levels in the DMS are still elevated after a 24-h withdrawal session, a time point that corresponds to the beginning of the next alcoholaccess session in this drinking protocol. Furthermore, administration of rFGF2 after a 24-h withdrawal period in the same drinking paradigm, either systemically to mice, or intra-dorsal striatum or intra-DMS to rats, increased alcohol drinking, whereas inhibition of FGF2 function at a similar time point had the opposite effect. These findings suggest that, throughout the alcohol drinking training, the increases in Fgf2 levels are likely leading to further increases in alcohol intake and preference in the next alcohol drinking sessions, possibly accounting for the escalation in drinking and maintaining high Fgf2 expression.
Interestingly, a positive feedback loop similar to the one we describe here with alcohol and FGF2 in the DMS has been reported with alcohol and AMPA receptor activity in the same brain region (Wang et al., 2012) . Thus, it was shown that excessive alcohol consumption increases synaptic AMPA receptor levels and function in the DMS (Wang et al., 2012) . Moreover, this AMPA receptor activity was shown to be vital for the expression of excessive alcohol consumption (Wang et al., 2012) . Relatedly, FGF2 was reported to increase the expression of the AMPA receptor subunit GluR1 (Cheng et al., 1995; Chew et al., 1997) , consequently increasing AMPA receptor function (Chew et al., 1997) . Although these interactions remain to be tested, it is plausible that, within the DMS, alcohol increases FGF2 expression, which in turn increases AMPA receptor activity, resulting in excessive alcohol consumption.
We found that the bidirectional interaction between alcohol and FGF2 was localized to the DMS. This brain region was suggested to play a role in the early stages of alcohol consumption, which are governed primarily by goal-directed behavior, before the behavior becomes habitual (Corbit et al., 2012) . Thus, the increase in FGF2 levels in the DMS, and its consequent enhancing effect on alcohol intake, may strengthen the response-outcome association, hence promoting engagement in alcohol-seeking and -drinking behaviors, and contributing to the development and maintenance of excessive alcohol-drinking behaviors.
Our results are in line with previous studies, which found that other drugs of abuse, such as amphetamine (Flores et al., 1998) , cocaine (Flores and Stewart, 2000b; Fumagalli et al., 2006) and nicotine (Roceri et al., 2001) , increase FGF2 levels in addictionrelated brain regions. In addition, the midbrain levels of FGF2 positively correlated with the magnitude of amphetamine psychomotor sensitization (Flores et al., 2000) . Moreover, Fgf2 mRNA expression and its epigenetic modifications in the rat NAc positively correlated with cocaine seeking and relapse (Flagel et al., 2016) . Finally, neonatal rFGF2 treatment enhanced cocaine self-administration and sensitization in adulthood Clinton et al., 2012) . Together with our present findings, these findings suggest that various drugs of abuse increase the brain expression of FGF2 and that high levels of FGF2 likely promote drug sensitization and consumption.
In conclusion, our results show that alcohol consumption increases the expression of Fgf2 within the DMS and that FGF2 increases alcohol intake by acting in this brain region. Therefore, our findings suggest that alcohol and FGF2 constitute a positive feedback loop, which contributes to the facilitation and maintenance of alcohol intake. Finally, together with previous reports, our findings suggest that FGF2 is a positive regulator of the consumption not only of alcohol, but also of other drugs of abuse.
